|  Home  |  Corpo Clínico  |  Perfil da Clínica  |  Hospitais de Referência  |  Localização  |  Contato  |                                                                           Need assistance?

14 de Março de 2025

Urologia - Informação sobre as principais doenças

Referências Bibliográficas

1. Etzioni R , Legler JM, Feuer EJ, ct al.Câncer surveillance series: interpreting trends in prostate cancer-part III : quantifying the link between population prostate-specific antigen ( esting and recent declines in prostate cancermortality ) JNatlCancerInst.1999;91:10331039.

2. Rics LAG, Kosary CL, Hankey BF, ct al, cds.SEER Cancer Statistics Review, 1973
1995.Bcthcsda, MD: National Cancer Instituct: 1998.

3. Yatani R, Chigusa I , Akazaki K, et al. Geographic pathology of latent prostatic carcinoma Int J Cancer. 1982;29:611-616.

4. Carter BS, Beaty TH, Steinberg GD, et al.Mendelian inheritancc of familial prostac cancer.Proc Natl Acad Sci USA. 1992;89:3367-3371.

5. Smith J, Freije D, Carpten J, ct al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide scarch.Science. 1996;274:1371-1374.

6. Wu YQ, Chen H, Rubin MA, et al.Loss of heterozygosity of the purative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.Cancer Res.2001;61:8651-8653.

7. Suarez BK,Gerhard DS, Lin J, ct al.Polymorphisms in the prostate cancer susceptibility gene HPC2 in multiplex familics and healthy controls.Cancer Res.2001;61:4982-4984.

8. Berthon P, Valeri A, Cohen-Akenine A, et al.Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.Am J Hum Genet.1998;62:1416-1424.

9. Xu J, Meyers D, Freije D, et al.Evidence for a prostate cancer susceptibility locus on the X chromosome.Nat Genet.1998;20:175-179.

10. Gibbis M, Standford J,Mclndoe R, et al.Evidence for a rare prostate cancersusceptibility locus at chromosome 1p36. Am J Hum Genet.1999;61:776-787.

11. Hsing AW,Tsao L,Devesa SS.International trends and patterns of prostate cancer incidence and mortality.Int J Cancer.2000;85:60-67.

12. Shimizu H, Ross RK, Bernstein L, ct al.Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles Country.Br J Cancer.1991;63:963-966.

13. GannHP: Risk Factors for prostate cancer Reviews in Urology;vol4Suppl5,3-10

14. Kolonel LN . Fat, meat, and prostate cancer.Epidemiol Rev.2001;23:72-81.

15. Klein EA: Opportunities for prevention of Prostate Cancer: Genetics,Chemoprevention and Dietary Intevention.Reviews in Urology; 2003 vol4 (Suppl5),18-28.
16. Giovonnucci E, Rimm EB, Wolk A, et al.Calcium and fructose intake in relation to risk of prostate cancer.Cancer Res.1998;58:442-447.

17. Clark LC, Combs GF, Turnbull BW, et al.Effects of selenium suplementation for cancer Prevention in patients with carcinoma of the skin:a randomized controlled trial.JAMA.1996;276:1957-1963.

18. Heinomen OP, Albanes D, Virtamo J, et al.Prostate cancer and supplementation whith alpha-tocopherol and beta-carotene:incidence and mortality in a controlled trial see comments. J Natl Cancer Inst.1998;90:440-446.

19. KleinEA, ThompsonIM, LippmanSM, et al.: SELECT:The next prostate cancer prevention trial.JUrol,1311-1315.

20. Gann PH, Ma J, Giovannucci E, et al.Lower prostac cancer risk in men with elevatcd plasma Iycopene levels: results of a prospective analysis.Cancer Res.1999;59:1225-1230.

21. Givannucci E, Clinton SK. Tomatoes,Iycopene, and cancer: review of the epidemiologic litcrature.J Natl Cancer Inst.1999;91:317-331.

22. Santibanez.JF, Navarro A, Martinez J.Genistein inhibits proliferation and in vitro invasive prolential of human prostatic cancer cell lines.Anticancer Res.1997;17:1199-1204.

23. Morton MS, Matos-Ferreira A, Abranches-Monteiro L, et al.Measurement and metabolism of isoflavonoids and lignans in human male.Cancer lell.1997;114:145-151.

24. Adlercreutz H, Markkanen H, Watanabe S.Plasma concentrations of phyto-oestrogens in a Japanese men.Lancet.1993;342:1209-1210.

25. Severson Rk, Grove JS, Nomura A, Stemmermann GN.Body mass and prostatic cancer:a prospective study.BMJ.1998;297:713-715.

26. Russel DW, Wilson JD.Steroid 5-alpha-reductasc:two genes/two cnzymcs.Annu Rev Biochem.1994;63:25-61.

27. Pollak M. Insulin-like growth factors and prostac cancer.Epidemiol Rev.2001;23:59-66.

28. Giovannucci E, Rimm EB, Stampfer MJ, et al.Diabetes mellitus and risk of prostac cancer (United States).Cancer Causes Control.1998;9:3-9

30. FugantiPE, Tobias-Machado,WroclawskiER: Dieta e Câncer de Próstata: aspectos atuais relacionados à quimioprevenção.RevBraMed,2003;6,39-46

31. Tobias-Machado, WroclawskiER, e col: Influência da dieta lipídica no risco de desenvolvimento do câncer de próstata. Anais Paulistas de Med e Cir, 2002,129;4-10

[ Voltar ]

Copyright© 2012 - Todos os direitos reservados - Melhor visualização em 1024 X 768

Instituto de Laparoscopia & Robótica
Rua Dona Adma Jafet, 74 Conjunto 77
Cep 01308-050, São Paulo - SP
Email: instituto@laparoscopia-robotica.com.br

Tel: +55 (11) 2729-5155 / Fax + 55 (11) 2729-9155